查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1825968

2025年恒温核酸增幅技术（INAAT）全球市场报告

Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，恒温核酸增幅技术 (INAAT) 市场快速扩张，从 2024 年的 39.4 亿美元成长到 2025 年的 43.3 亿美元，复合年增长率为 10.0%。预测期内的成长将由感染疾病诊断、就地检验(POCT)、结核病控制、分子诊断和新兴市场推动。

预计未来几年，恒温核酸增幅技术 (INAAT) 市场将快速成长，到 2029 年将达到 74.4 亿美元，复合年增长率为 14.5%。预测期内的成长可归因于疫情应对措施、抗生素抗药性、环境监测、肿瘤诊断和全球卫生倡议。预测期内的主要趋势包括多路復用、微型化、数位检测、样本到结果係统以及基因编辑整合。

恒温核酸增幅技术 (INAAT) 是一种用于扩增 DNA 样本的方法。 INAAT 允许在恆定温度下扩增来自两个不同核酸片段的 DNA 序列。

与恒温核酸增幅技术相关的主要产品类型包括仪器和试剂。试剂是指引入系统以诱导化学反应或确定反应是否发生的物质或化合物。 NASBA 和 HAD 等各种技术通常用于血液筛检、感染疾病诊断和癌症相关分析等领域。该技术的最终用户是医院、参考实验室和其他机构。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗保健领域产生了重大影响，尤其是对基本医疗设备、诊断设备和药品的供应。医院和医疗机构正疲于应对进口手术器械、诊断影像系统以及注射器和导管等消耗品不断上涨的成本，而这些产品中的许多在国内的替代品有限。由于这些不断上涨的成本给医疗保健预算带来压力，一些医疗机构正在推迟设备升级或将增加的费用转嫁给患者。此外，原料和零件的关税扰乱了关键药品和医疗设备的生产，导致供应链延迟。作为应对措施，该行业正在采用多样化的筹资策略，尽可能扩大本地生产，并游说对关键医疗产品免关税。

本研究报告是商业研究公司（The Business Research Company）新报告系列的一部分，该系列提供恒温核酸增幅技术 (INAAT) 市场统计数据，例如全球市场规模、各地区份额、竞争对手的恒温核酸增幅恒温核酸增幅技术 (INAAT) 市场份额、详细的恒温核酸增幅恒温核酸增幅(INAAT) 细分市场、市场、市场和市场成功，以及您在市场等产业成功的全球阶段 (INAAT) 市场、市场、市场本恒温核酸增幅技术 (INAAT) 市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

未来五年14.5%的成长预测比我们先前的预测略有下降0.2%。这一下降主要归因于美国与其他国家之间关税的影响。关税上涨可能会对美国诊断实验室造成压力，因为它会增加从新加坡和韩国采购的可携式INAAT检测平台和试剂的成本，加剧就地检验的延误，并增加传染病筛检的成本。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，其影响也将更加广泛。

感染疾病和慢性病的日益普及是恒温核酸增幅技术 (INAAT) 市场扩张的关键驱动力。流感嗜血桿菌、肺炎链球菌（呼吸道感染疾病）、淋病奈瑟菌、沙眼衣原体（生殖器感染疾病）和结核病 (TB) 等疾病的增多，需要恒温核酸增幅技术 (INAAT) 等诊断解决方案。根据世界卫生组织 (WHO) 统计，全球每年约有 1000 万人感染结核病，导致 150 万人死亡。感染疾病和慢性病的日益普及正刺激恒温核酸增幅技术市场的扩张。

政府针对医疗保健研究和开发的倡议预计将显着促进恒温核酸增幅技术市场的未来成长。这些倡议包括政府机构为解决各种医疗保健问题而采取的具体行动、计划和措施，包括对恒温核酸增幅技术的支援。 2022 年，英国卫生和社会保障部 (DHSC) 宣布承诺提供 2.6 亿英镑（2.7065 亿美元）的资金，以促进医疗保健研究和製造。该资金由商业、能源和工业战略部 (BEIS) 和 DHSC 设立，旨在促进 NHS主导的医学研究、保护隐私的诊断和治疗平台，并加强英国的生命科学製造业。因此，政府专注于医疗保健研究和开发的措施正在推动恒温核酸增幅技术市场的发展。

奈米结构越来越多地被应用于体外诊断和快速诊断检测 (RDT)，以提高现有检测的有效性，并开发用于照护现场应用的创新诊断方法。奈米结构和奈米技术利用奈米粒子来改善治疗环境中的药物作用。奈米技术是透过在奈米尺度上精确操控尺寸和形态来设计、表征、製造和应用设备、结构和系统。目前已发展出多种梅毒诊断的 RDT，包括 AccuBioTech（Accu-Tell 快速梅毒检测）、Alere, Inc.（Alere Determine）、Alere/Standard Diagnostics（SD Syphilis 3.0）、The Tulip Group/Qualpro（Syphicheck-WB）、Cypress Diagnostics（Syphpress）快速检测）。这些 RDT 使患者能够在即时诊断 (POC) 时获得诊断。

恒温核酸增幅技术市场的主要企业正在率先推出像 QIAstat-Dx 症候群检测解决方案这样的创新解决方案，以获得竞争优势。 QIAstat-Dx 系统是一个整合的多重分子检测平台，可在单一试剂盒中完成样品製备、核酸扩增和检测。例如，2023 年 4 月，总部位于荷兰、专注于为各种应用提供恒温核酸增幅技术 (INAAT) 的公司 Qiagen 推出了 QIAstat-Dx 症候群检测解决方案。该系统提供 Ct（循环阈值）值和扩增曲线，使临床医生能够监测扩增进展并做出明智的诊断决策。

2023年2月，美国生技公司Sherlock Biosciences收购了Sense Biodetection，收购金额未揭露。此次收购将使Sherlock能够透过将Sense基于LAMP的技术与先进的CRISPR方法结合，增强其诊断能力，从而提高分子检测的速度和可及性。总部位于英国的Sense Biodetection专注于利用恒温核酸增幅技术（尤其是环介导等温扩增技术，LAMP）开发快速的照护现场诊断解决方案。

恒温核酸增幅技术 (INAAT) 市场的主要企业包括 Alere Inc.、biomeriux SA、Qiagen NV、Becton、Dickson & Company、Hologica Inc.、Lucigen Corporation、Quidel Corporation、New England Biolabs Inc.、NuTech、Ustar BIoTechnologies Ltd.、ThemoBiopell Ltd. Corporation、Sony Corporation、Panasonic Holdings Corporation、Toshiba Corporation、Rohm Co Ltd.、PhilipsHologic-Gen-Probe、BetaLED、Avago Technologies Ltd.、Grifols SA、Abbott Laboratories、Jena Bioscience GmbH、Atila Biosystems Incorporated、TwistDx Ltd.、LGC Ltd.、DiaGene)。

2024年，恒温核酸增幅技术 (INAAT) 市场最大的地区是北美。西欧是恒温核酸增幅技术 (INAAT) 市场的第二大地区。恒温核酸增幅技术 (INAAT) 市场报告涵盖的地区包括亚太地区、西欧、东欧、北美、南美、中东和非洲。

恒温核酸增幅技术（INAAT）市场报告涵盖国家：澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、义大利、西班牙、加拿大

恒温核酸增幅技术 (INAAT) 市场包括反应系统及相关服务的收益。市场规模包括服务供应商销售或包含在服务产品中的相关产品的价值。它仅包括营业单位之间交易或销售给最终消费者的商品和服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球恒温核酸增幅技术（INAAT）：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球恒温核酸增幅技术（INAAT）市场：成长率分析
  • 全球恒温核酸增幅技术 (INAAT) 市场表现：规模与成长，2019-2024 年
  • 全球恒温核酸增幅技术 (INAAT) 市场预测：规模与成长，2024-2029 年，2034 年
  • 全球恒温核酸增幅技术（INAAT）：总目标市场（TAM）

第六章 市场细分

  • 全球恒温核酸增幅技术（INAAT）市场（依产品、效能及预测），2019-2024 年、2024-2029 年、2034 年
  • 装置
  • 试剂
  • 全球恒温核酸增幅技术（INAAT）市场技术、效能及预测（2019-2024、2024-2029、2034）
  • NASBA
  • HAD
  • 全球恒温核酸增幅技术（INAAT）市场的应用、效能与预测，2019-2024年、2024-2029年、2034年
  • 血液检查
  • 感染疾病诊断
  • 癌症
  • 全球恒温核酸增幅技术 (INAAT) 市场（按最终用户、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 参考实验室
  • 其他的
  • 全球恒温核酸增幅技术（INAAT）市场：仪器细分、类型、效能及预测，2019-2024年、2024-2029年、2034年
  • 可携式设备
  • 桌上型装置
  • 全球恒温核酸增幅技术（INAAT）市场：试剂细分、类型、效能及预测，2019-2024年、2024-2029年、2034年
  • 酵素
  • 引子和探针
  • 缓衝液和其他试剂

第七章 区域和国家分析

  • 全球恒温核酸增幅技术（INAAT）市场各地区、绩效及预测（2019-2024年、2024-2029年、2034年）
  • 全球恒温核酸增幅技术（INAAT）市场（依国家、绩效及预测），2019-2024年、2024-2029年、2034年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 恒温核酸增幅技术（INAAT）市场：竞争格局
  • 恒温核酸增幅技术（INAAT）市场：公司简介
    • Alere Inc.
    • biomeriux SA
    • Qiagen NV
    • Becton, Dickson & Company
    • Hologica Inc.

第31章：其他领先和创新企业

  • Lucigen Corporation
  • Quidel Corporation
  • New England Biolabs Inc.
  • NuGen
  • Ustar BIoTechnologies Ltd.
  • Thermo Fisher Scientific Inc.
  • BioHelix Corporation
  • Meridian Bioscience Inc.
  • Novartis AG
  • Sharp Corporation
  • Sony Corporation
  • Panasonic Holdings Corporation
  • Toshiba Corporation
  • Rohm Co Ltd.
  • PhilipsHologic-Gen-Probe

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年恒温核酸增幅技术（INAAT）市场：提供新机会的国家
  • 恒温核酸增幅技术 (INAAT) 市场，2029 年：提供新机会的细分市场
  • 恒温核酸增幅技术（INAAT）市场2029年：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r32621u

Isothermal nucleic acid amplification technology (INAAT) is a method employed for amplifying DNA samples. INAAT enables the amplification of DNA sequences from two different nucleic acid segments at a constant temperature.

The primary product types associated with isothermal nucleic acid amplification technology include instruments and reagents. Reagents are substances or compounds introduced into a system to induce a chemical reaction or to determine whether a reaction has occurred. Various technologies, such as NASBA and HAD, are used in this context and are typically applied in areas like blood screening, infectious disease diagnostics, and cancer-related analyses. The end users of this technology encompass hospitals, reference laboratories, and other institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The isothermal nucleic acid amplification technology (INAAT) market research report is one of a series of new reports from The Business Research Company that provides isothermal nucleic acid amplification technology (INAAT) market statistics, including isothermal nucleic acid amplification technology (INAAT) industry global market size, regional shares, competitors with a isothermal nucleic acid amplification technology (INAAT) market share, detailed isothermal nucleic acid amplification technology (INAAT) market segments, market trends and opportunities, and any further data you may need to thrive in the isothermal nucleic acid amplification technology (INAAT) industry. This isothermal nucleic acid amplification technology (INAAT) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The isothermal nucleic acid amplification technology (inaat) market size has grown rapidly in recent years. It will grow from $3.94 billion in 2024 to $4.33 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to infectious disease diagnostics, point-of-care testing (poct), tuberculosis control, molecular diagnostics, emerging markets.

The isothermal nucleic acid amplification technology (inaat) market size is expected to see rapid growth in the next few years. It will grow to $7.44 billion in 2029 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to pandemic preparedness, antimicrobial resistance, environmental monitoring, oncology diagnostics, global health initiatives. Major trends in the forecast period include multiplexing, miniaturization, digital detection, sample-to-answer systems, gene editing integration.

The forecast of 14.5% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. diagnostic labs by driving up the cost of portable INAAT testing platforms and reagents sourced from Singapore and South Korea, exacerbating point-of-care testing delays and increasing infectious disease screening costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising incidence of Infectious and Chronic Diseases is a significant driver behind the expansion of the Isothermal Nucleic Acid Amplification Technology (INAAT) market. Diseases such as H. influenzae, S. pneumonia (respiratory tract infections), N. gonorrhoeae, C. trachomatis (genital infections), and TB are on the increase, demanding diagnostic solutions like isothermal nucleic acid amplification technology (INAAT). According to the World Health Organization (WHO), an estimated 10 million people contract tuberculosis every year, resulting in 1.5 million deaths. The growing prevalence of infectious and chronic diseases is a key factor fueling the expansion of the isothermal nucleic acid amplification technology market.

Government initiatives aimed at healthcare research and development are poised to significantly drive the growth of the isothermal nucleic acid amplification technology market in the future. These initiatives involve specific actions, programs, or policies launched by government entities to tackle various healthcare issues, including supporting isothermal nucleic acid amplification technology. In 2022, the UK's Department of Health and Social Care (DHSC) announced a £260 million ($270.65 million) funding commitment to foster healthcare research and manufacturing. This funding, established by the Department for Business, Energy and Industrial Strategy (BEIS) and DHSC, aims to facilitate NHS-led health research, privacy-preserving platforms for diagnostics and treatments, and bolster life sciences manufacturing in the UK. Hence, government initiatives focused on healthcare research and development are propelling the isothermal nucleic acid amplification technology market.

Nanostructures are increasingly integrated into in vitro diagnostics and in vitro rapid diagnostic tests (RDTs) to enhance existing tests' effectiveness and develop innovative diagnostic approaches for point-of-care applications. Nanostructures and nanotechnology employ nanoparticles to improve drug actions in treatments. Nanotechnology entails designing, characterizing, producing, and applying devices, structures, and systems by precisely manipulating size and shape at the nanometer scale. Several RDTs have been created for syphilis diagnosis, such as AccuBioTech (Accu-Tell Rapid Syphilis Test), Alere, Inc. (Alere Determine), Alere/Standard Diagnostics (SD Syphilis 3.0), The Tulip Group/Qualpro (Syphicheck - WB), Cypress Diagnostics (Syphilis Rapid Test), and Omega Diagnostics (Visitect Syphilis). These RDTs enable patients to receive diagnoses at the point of care (POC).

Major companies operating in the isothermal nucleic acid amplification technology market are developing innovative solutions like the QIAstat-Dx syndromic testing solution to gain a competitive advantage. The QIAstat-Dx system is an integrated, multiplexed molecular testing platform that combines sample preparation, nucleic acid amplification, and detection within a single cartridge. For instance, in April 2023, Qiagen, a Netherlands-based company specializing in isothermal nucleic acid amplification technology (INAAT) for various applications, introduced the QIAstat-Dx syndromic testing solution. This system provides Ct (cycle threshold) values and access to amplification curves, allowing clinicians to monitor amplification progress and make well-informed diagnostic decisions.

In February 2023, Sherlock Biosciences, a U.S.-based biotechnology company, acquired Sense Biodetection for an undisclosed amount. This acquisition allows Sherlock to enhance its diagnostic capabilities by integrating Sense's LAMP-based technology with its advanced CRISPR methodologies, thereby improving the speed and accessibility of molecular testing. Sense Biodetection, a UK-based company, specializes in developing rapid, point-of-care diagnostic solutions that utilize isothermal nucleic acid amplification technology, particularly Loop-Mediated Isothermal Amplification (LAMP).

Major companies operating in the isothermal nucleic acid amplification technology (inaat) market include Alere Inc., biomeriux SA, Qiagen NV, Becton, Dickson & Company, Hologica Inc., Lucigen Corporation, Quidel Corporation, New England Biolabs Inc., NuGen, Ustar Biotechnologies Ltd., Thermo Fisher Scientific Inc., BioHelix Corporation, Meridian Bioscience Inc., Novartis AG, Sharp Corporation, Sony Corporation, Panasonic Holdings Corporation, Toshiba Corporation, Rohm Co Ltd., PhilipsHologic-Gen-Probe, BetaLED, Avago Technologies Ltd., Grifols SA, Abbott Laboratories, Jena Bioscience GmbH, Atila Biosystems Incorporated, TwistDx Ltd., LGC Ltd., DiaSorin SpA, OptiGene Limited

North America was the largest region in the isothermal nucleic acid amplification technology (INAAT) market in 2024. Western Europe was the second largest region in the isothermal nucleic acid amplification technology (INAAT) market. The regions covered in the isothermal nucleic acid amplification technology (inaat) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the isothermal nucleic acid amplification technology (inaat) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The isothermal nucleic acid amplification technology (INAAT) market includes revenues earned by reaction systems and related services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on isothermal nucleic acid amplification technology (inaat) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for isothermal nucleic acid amplification technology (inaat) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The isothermal nucleic acid amplification technology (inaat) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Instrument; Reagent
  • 2) By Technology: NASBA; HAD
  • 3) By Application: Blood Screening; Infectious Disease Diagnostics; Cancer
  • 4) By End-User: Hospital; Reference Laboratories; Other End-Users
  • Subsegments:
  • 1) By Instrument: Portable Instruments; Benchtop Instruments
  • 2) By Reagent: Enzymes; Primers And Probes; Buffers And Other Reagents
  • Companies Mentioned: Alere Inc.; biomeriux SA; Qiagen NV; Becton, Dickson & Company; Hologica Inc.; Lucigen Corporation; Quidel Corporation; New England Biolabs Inc.; NuGen; Ustar Biotechnologies Ltd.; Thermo Fisher Scientific Inc.; BioHelix Corporation; Meridian Bioscience Inc.; Novartis AG; Sharp Corporation; Sony Corporation; Panasonic Holdings Corporation; Toshiba Corporation; Rohm Co Ltd.; PhilipsHologic-Gen-Probe; BetaLED; Avago Technologies Ltd.; Grifols SA; Abbott Laboratories; Jena Bioscience GmbH; Atila Biosystems Incorporated; TwistDx Ltd.; LGC Ltd.; DiaSorin SpA; OptiGene Limited
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Characteristics

3. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Trends And Strategies

4. Isothermal Nucleic Acid Amplification Technology (INAAT) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Isothermal Nucleic Acid Amplification Technology (INAAT) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth Rate Analysis
  • 5.4. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Total Addressable Market (TAM)

6. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Segmentation

  • 6.1. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instrument
  • Reagent
  • 6.2. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • NASBA
  • HAD
  • 6.3. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Screening
  • Infectious Disease Diagnostics
  • Cancer
  • 6.4. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital
  • Reference Laboratories
  • Other End-Users
  • 6.5. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Sub-Segmentation Of Instrument, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Portable Instruments
  • Benchtop Instruments
  • 6.6. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Sub-Segmentation Of Reagent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Enzymes
  • Primers and Probes
  • Buffers and Other Reagents

7. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Regional And Country Analysis

  • 7.1. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 8.1. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 9.1. China Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 9.2. China Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 10.1. India Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 11.1. Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 11.2. Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 12.1. Australia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 13.1. Indonesia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 14.1. South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 14.2. South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 15.1. Western Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 15.2. Western Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 16.1. UK Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 17.1. Germany Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 18.1. France Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 19.1. Italy Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 20.1. Spain Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 21.1. Eastern Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 21.2. Eastern Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 22.1. Russia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 23.1. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 23.2. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 24.1. USA Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 24.2. USA Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 25.1. Canada Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 25.2. Canada Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 26.1. South America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 26.2. South America Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 27.1. Brazil Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 28.1. Middle East Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 28.2. Middle East Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 29.1. Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 29.2. Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Competitive Landscape And Company Profiles

  • 30.1. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Competitive Landscape
  • 30.2. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Company Profiles
    • 30.2.1. Alere Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. biomeriux SA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Qiagen NV Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Becton, Dickson & Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Hologica Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Other Major And Innovative Companies

  • 31.1. Lucigen Corporation
  • 31.2. Quidel Corporation
  • 31.3. New England Biolabs Inc.
  • 31.4. NuGen
  • 31.5. Ustar Biotechnologies Ltd.
  • 31.6. Thermo Fisher Scientific Inc.
  • 31.7. BioHelix Corporation
  • 31.8. Meridian Bioscience Inc.
  • 31.9. Novartis AG
  • 31.10. Sharp Corporation
  • 31.11. Sony Corporation
  • 31.12. Panasonic Holdings Corporation
  • 31.13. Toshiba Corporation
  • 31.14. Rohm Co Ltd.
  • 31.15. PhilipsHologic-Gen-Probe

32. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Isothermal Nucleic Acid Amplification Technology (INAAT) Market

34. Recent Developments In The Isothermal Nucleic Acid Amplification Technology (INAAT) Market

35. Isothermal Nucleic Acid Amplification Technology (INAAT) Market High Potential Countries, Segments and Strategies

  • 35.1 Isothermal Nucleic Acid Amplification Technology (INAAT) Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer